John Afees Olanrewaju
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
John Afees Olanrewaju has a total of 65 co-authors. Here are the top co-authors by number of shared publications:
- Ezekiel Abiola Olugbogi
Babcock University
4 shared publications - Leviticus Arietarhire
Department of Anatomy, Benjamin Carson College of Medicine, Babcock University, Ilishan-Remo, Nigeria
4 shared publications - Oladimeji Emmanuel Soremekun
Department of Pharmacology and Therapeutics, College of Medicine, University of Ibadan, Ibadan, Nigeria
4 shared publications - Ayodeji Zabdiel Abijo
Department of Anatomy Ben Carson School of Medicine Babcock University Ilisan-Remo Ogun State Nigeria
3 shared publications - Joshua Owolabi
Department of Biomedical Sciences, Philadelphia College of Osteopathic Medicine, Moultrie, USA
3 shared publications Stephen Taiye Adelodun
Department of Anatomy, Ben Carson School of Medicine, Babcock University, Ilishan-Remo, Ogun State, Nigeria
3 shared publications
Latest Publications
- Open Access
- 28 August 2026
- Published by Springer Nature in Bulletin of the National Research Centre
- Vol. 50 (1) , 90
Hibiscus sabdariffa ameliorates tramadol-induced neurotoxicity via antioxidant, anti-inflammatory, anti-apoptotic, and neurotransmission-regulating mechanisms
Introduction: The misuse and abuse of tramadol, a synthetic opioid analgesic, has become a major public health concern in Africa. Although effective for managing moderate to severe pain, tramadol exposure has been associated with central nervous system toxicity. Hibiscus sabdariffa , commonly consumed as “Zobo,” contains bioactive substances with potent antioxidant and anti-inflammatory properties. Therefore, this study investigated the neuroprotective potential of aqueous H. sabdariffa extract (HSE) against tramadol-induced neurotoxicity in male Swiss mice. Methodology: Fifty adult male mice were randomly assigned into five groups namely control (normal saline), tramadol (50 mg/kg), and three treatment groups receiving tramadol intraperitoneally plus HSE given through oral route at 50, 100, and 200 mg/kg for 21 days. Neurobehavioral tests assessed motor coordination, cognition, anxiety, and depressive-like behaviors. Brain regions, including the hippocampus, prefrontal cortex, and cerebellum, were analyzed for malondialdehyde, reduced glutathione, catalase, superoxide dismutase, glutathione-S-transferase, nitrite levels, acetylcholinesterase activity, and pro-inflammatory cytokines, including interleukin-6, and tumour necrosis factor-alpha. Histological analysis was performed using Nissl staining, while RT-PCR quantified neurotransmission- and apoptosis-related genes, including GAD2, TH, TP53, BAX, and BCL-2. Molecular docking evaluated interactions of H. sabdariffa phytocompounds with target proteins. Results: Tramadol exposure significantly impaired behavior, increased oxidative stress and inflammation, depleted antioxidant defenses, and induced neuronal damage with altered gene expression. H. sabdariffa extract treatment dose-dependently mitigated these alterations, preserved neuronal architecture, and modulated apoptosis-related genes. Docking computation identified Quercetin-3-O-rutinoside, Baicalin, and Delphinidin-3-O-sambubioside as hit compounds with strong binding affinity to target proteins of the genes evaluated in the RT-PCR. Conclusion: Hibiscus sabdariffa aqueous extract activity suggests robust neuroprotective effects against tramadol-induced neurotoxicity through coordinated antioxidant, anti-inflammatory, anti-apoptotic, and neuromodulatory mechanisms. These findings position H. sabdariffa extract as a promising, accessible therapeutic candidate for managing opioid-induced CNS damage.
- 28 August 2026
- Published by Springer Nature in Bulletin of the National Research Centre
- Vol. 50 (1) , 90
Open AccessHibiscus sabdariffa ameliorates tramadol-induced neurotoxicity via antioxidant, anti-inflammatory, anti-apoptotic, and neurotransmission-regulating mechanisms
Introduction: The misuse and abuse of tramadol, a synthetic opioid analgesic, has become a major public health concern in Africa. Although effective for managing moderate to severe pain, tramadol exposure has been associated with central nervous system toxicity. Hibiscus sabdariffa , commonly consumed as “Zobo,” contains bioactive substances with potent antioxidant and anti-inflammatory properties. Therefore, this study investigated the neuroprotective potential of aqueous H. sabdariffa extract (HSE) against tramadol-induced neurotoxicity in male Swiss mice. Methodology: Fifty adult male mice were randomly assigned into five groups namely control (normal saline), tramadol (50 mg/kg), and three treatment groups receiving tramadol intraperitoneally plus HSE given through oral route at 50, 100, and 200 mg/kg for 21 days. Neurobehavioral tests assessed motor coordination, cognition, anxiety, and depressive-like behaviors. Brain regions, including the hippocampus, prefrontal cortex, and cerebellum, were analyzed for malondialdehyde, reduced glutathione, catalase, superoxide dismutase, glutathione-S-transferase, nitrite levels, acetylcholinesterase activity, and pro-inflammatory cytokines, including interleukin-6, and tumour necrosis factor-alpha. Histological analysis was performed using Nissl staining, while RT-PCR quantified neurotransmission- and apoptosis-related genes, including GAD2, TH, TP53, BAX, and BCL-2. Molecular docking evaluated interactions of H. sabdariffa phytocompounds with target proteins. Results: Tramadol exposure significantly impaired behavior, increased oxidative stress and inflammation, depleted antioxidant defenses, and induced neuronal damage with altered gene expression. H. sabdariffa extract treatment dose-dependently mitigated these alterations, preserved neuronal architecture, and modulated apoptosis-related genes. Docking computation identified Quercetin-3-O-rutinoside, Baicalin, and Delphinidin-3-O-sambubioside as hit compounds with strong binding affinity to target proteins of the genes evaluated in the RT-PCR. Conclusion: Hibiscus sabdariffa aqueous extract activity suggests robust neuroprotective effects against tramadol-induced neurotoxicity through coordinated antioxidant, anti-inflammatory, anti-apoptotic, and neuromodulatory mechanisms. These findings position H. sabdariffa extract as a promising, accessible therapeutic candidate for managing opioid-induced CNS damage.
- Open Access
- 3 February 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (3) , 1510
Targeting Matrix Stiffness and Mechanotransduction in Breast Cancer: Implications for Emerging Therapies
Breast cancer remains a leading cause of mortality among women worldwide. The inherent heterogeneity in tumors among patients with breast cancer poses a challenge to effective therapeutic management. The extracellular matrix (ECM) is an important structural component of the tumor microenvironment (TME) that regulates cellular behavior. When the ECM adopts a stiff configuration, this coincides with biochemical remodeling in response to biomechanical cues that drive tumor cell invasion, immune evasion, and metastatic spread in breast cancer. Emerging studies suggest that patient ancestry significantly impacts ECM stiffness to contribute to disparities in breast cancer survival. In this review, we discuss recent advances in our understanding of how the tumor ECM orchestrates breast cancer invasion and metastasis through mechanotransduction signaling to promote breast cancer progression. We also discuss ancestry-associated differences in breast ECM architecture and agents targeting mechanotransduction signaling pathways with potential to treat breast cancer and improve patient outcomes. Collectively, this review will highlight the significance of tumor mechanobiology and present emerging therapies that target stiffness-sensitive mechanotransduction pathways. By integrating mechanistic insights with therapeutic innovation, we aim to support the development of ECM-targeted therapies to enable more efficacious treatment of aggressive breast cancer subtypes.
- 3 February 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (3) , 1510
Open AccessTargeting Matrix Stiffness and Mechanotransduction in Breast Cancer: Implications for Emerging Therapies
Breast cancer remains a leading cause of mortality among women worldwide. The inherent heterogeneity in tumors among patients with breast cancer poses a challenge to effective therapeutic management. The extracellular matrix (ECM) is an important structural component of the tumor microenvironment (TME) that regulates cellular behavior. When the ECM adopts a stiff configuration, this coincides with biochemical remodeling in response to biomechanical cues that drive tumor cell invasion, immune evasion, and metastatic spread in breast cancer. Emerging studies suggest that patient ancestry significantly impacts ECM stiffness to contribute to disparities in breast cancer survival. In this review, we discuss recent advances in our understanding of how the tumor ECM orchestrates breast cancer invasion and metastasis through mechanotransduction signaling to promote breast cancer progression. We also discuss ancestry-associated differences in breast ECM architecture and agents targeting mechanotransduction signaling pathways with potential to treat breast cancer and improve patient outcomes. Collectively, this review will highlight the significance of tumor mechanobiology and present emerging therapies that target stiffness-sensitive mechanotransduction pathways. By integrating mechanistic insights with therapeutic innovation, we aim to support the development of ECM-targeted therapies to enable more efficacious treatment of aggressive breast cancer subtypes.
- 14 August 2024
- Published by Springer Nature in In Silico Pharmacology
- Vol. 12 (2) , 1-19
Reporting the anti-neuroinflammatory potential of selected spondias mombin flavonoids through network pharmacology and molecular dynamics simulations
Neuroinflammation plays a pivotal role in the development and progression of neurodegenerative diseases, with a complex interplay between immune responses and brain activity. Understanding this interaction is crucial for identifying therapeutic targets and developing effective treatments. This study aimed to explore the neuroprotective properties of flavonoid compounds from Spondias mombin via the modulation of neuroinflammatory pathway using a comprehensive in-silico approach, including network pharmacology, molecular docking, and dynamic simulations. Active flavonoid ingredients from S. mombin were identified, and their potential protein targets were predicted through Network Pharmacology. Molecular docking was conducted to determine the binding affinities of these compounds against targets obtained from network pharmacology, prioritizing docking scores ≥ − 8.0 kcal/mol. Molecular dynamic simulations (MDS) assessed the stability and interaction profiles of these ligand–protein complexes. The docking study highlighted ≥ − 8.0 kcal/mol for the ligands (catechin and epicatechin) against FYN kinase as a significant target. However, these compounds failed the blood–brain barrier (BBB) permeability test. MDS confirmed the stability of catechin and the reference ligand at the FYN kinase active site, with notable interactions involving hydrogen bonds, hydrophobic contacts, and water bridges. GLU54 emerged as a key residue in the catechin-FYN complex stability due to its prolonged hydrogen bond interaction. The findings underscore the potential of S. mombin flavonoids as therapeutic agents against neuroinflammation, though optimization and nanotechnology-based delivery methods are suggested to enhance drug efficacy and overcome BBB limitations. Graphical abstract
- 14 August 2024
- Published by Springer Nature in In Silico Pharmacology
- Vol. 12 (2) , 1-19
Reporting the anti-neuroinflammatory potential of selected spondias mombin flavonoids through network pharmacology and molecular dynamics simulations
Neuroinflammation plays a pivotal role in the development and progression of neurodegenerative diseases, with a complex interplay between immune responses and brain activity. Understanding this interaction is crucial for identifying therapeutic targets and developing effective treatments. This study aimed to explore the neuroprotective properties of flavonoid compounds from Spondias mombin via the modulation of neuroinflammatory pathway using a comprehensive in-silico approach, including network pharmacology, molecular docking, and dynamic simulations. Active flavonoid ingredients from S. mombin were identified, and their potential protein targets were predicted through Network Pharmacology. Molecular docking was conducted to determine the binding affinities of these compounds against targets obtained from network pharmacology, prioritizing docking scores ≥ − 8.0 kcal/mol. Molecular dynamic simulations (MDS) assessed the stability and interaction profiles of these ligand–protein complexes. The docking study highlighted ≥ − 8.0 kcal/mol for the ligands (catechin and epicatechin) against FYN kinase as a significant target. However, these compounds failed the blood–brain barrier (BBB) permeability test. MDS confirmed the stability of catechin and the reference ligand at the FYN kinase active site, with notable interactions involving hydrogen bonds, hydrophobic contacts, and water bridges. GLU54 emerged as a key residue in the catechin-FYN complex stability due to its prolonged hydrogen bond interaction. The findings underscore the potential of S. mombin flavonoids as therapeutic agents against neuroinflammation, though optimization and nanotechnology-based delivery methods are suggested to enhance drug efficacy and overcome BBB limitations. Graphical abstract
- Open Access
- 3 January 2024
- Published by Springer Nature in Research Square
Genetic Associations and Functional Pathways in Parkinson's Disease: A Meta-Analytic Insight into LRRK2 Mutation Impact
Background: Parkinson's Disease (PD) is a complex neurodegenerative disorder with elusive pathophysiological mechanisms. Recent studies have highlighted the role of genetic variations and metabolic changes in PD progression. Aim: This study aims to investigate the genetic disparities in PD, particularly focusing on LRRK2 mutations, and to analyze the associated metabolic pathway alterations. Methodology: The study utilized R programming with MetaIntegrator for meta-analysis and ggplot2 for visualization. Datasets underwent preprocessing, and the MetaIntegrator package computed meta scores, effects, and ROC analysis. Differential gene expression and functional enrichment analyses provided insights into genetic associations and pathways in Parkinson's disease and LRRK2 mutations. Results: Significant meta-score differences were observed in PD patients, especially in datasets GSE133347, GSE36321, and GSE100054, underscoring the impact of LRRK2 mutations. Genes like SKAP2 and IFNGR2 were significantly upregulated, implicating their role in neuroinflammation. Moreover, a shift in metabolic pathways, particularly carbohydrate kinase activity, was noted, indicating altered energy metabolism in PD cells. Conclusion: The study reinforces the genetic heterogeneity of PD and highlights the potential therapeutic importance of targeting neuroinflammatory pathways and metabolic dysfunctions. These findings suggest new avenues for diagnostic and therapeutic strategies in PD management.
- 3 January 2024
- Published by Springer Nature in Research Square
Open AccessGenetic Associations and Functional Pathways in Parkinson's Disease: A Meta-Analytic Insight into LRRK2 Mutation Impact
Background: Parkinson's Disease (PD) is a complex neurodegenerative disorder with elusive pathophysiological mechanisms. Recent studies have highlighted the role of genetic variations and metabolic changes in PD progression. Aim: This study aims to investigate the genetic disparities in PD, particularly focusing on LRRK2 mutations, and to analyze the associated metabolic pathway alterations. Methodology: The study utilized R programming with MetaIntegrator for meta-analysis and ggplot2 for visualization. Datasets underwent preprocessing, and the MetaIntegrator package computed meta scores, effects, and ROC analysis. Differential gene expression and functional enrichment analyses provided insights into genetic associations and pathways in Parkinson's disease and LRRK2 mutations. Results: Significant meta-score differences were observed in PD patients, especially in datasets GSE133347, GSE36321, and GSE100054, underscoring the impact of LRRK2 mutations. Genes like SKAP2 and IFNGR2 were significantly upregulated, implicating their role in neuroinflammation. Moreover, a shift in metabolic pathways, particularly carbohydrate kinase activity, was noted, indicating altered energy metabolism in PD cells. Conclusion: The study reinforces the genetic heterogeneity of PD and highlights the potential therapeutic importance of targeting neuroinflammatory pathways and metabolic dysfunctions. These findings suggest new avenues for diagnostic and therapeutic strategies in PD management.
- Open Access
- 29 December 2023
- Published by Springer Nature in Research Square
Spondias mombin flavonoids showed super-binder ability with Downstream Molecular Targets of Parkinson’s Disease: Folkloric-therapy assessment as a Scaffold for Structural Studies in Neurodegenerative disease
Spondias mombin (S. mombin), a prominent botanical resource, has garnered recognition within folkloric therapy. Parkinson's disease (PD), characterized by dopaminergic neuron attrition in the substantia nigra, manifests as motor anomalies like tremors, rigidity, and bradykinesia. This study capitalizes on S. mombin's reservoir of 100 characterized phytocompounds and employs computational methodologies to interrogate their potential 35 PD-associated target proteins. Employing a multifaceted approach, we engaged in molecular docking, ADMET predictions, Molecular Mechanics/Generalized Born Surface Area (MM/GBSA) evaluations, Density Functional Theory (DFT), and Molecular Dynamic Simulations (MDS). This comprehensive framework facilitated insightful structural assessments and predictive analyses. Impressively, flavonoids hailing from S. mombin, including quercetin, catechin, ellagic acid, and epicatechin, showcased optimal binding affinities for PD-relevant target proteins. Moreover, these identified ligands exhibited minimal signs of mutagenicity, tumorigenicity, or irritancy, except for quercetin, which displayed elevated tumorigenic potential. Notably, quercetin and dopamine exhibited varying band gap energies, with quercetin the lowest (3.63 eV) and dopamine the highest (5.76 eV) values. MDS result suggests a synergistic outcome based on the RMSD and RMSF graphs for quercetin highlighting it as the best of all including the co-ligand. In a collective sense, our findings present S. mombin as promising reservoirs of active pharmaceutical ingredients, warranting further exploration for novel PD therapeutic avenues. Consequently, this study underscores the enhanced efficacy of phyto-ligands sourced from S. mombin, advocating their optimization as potential drug candidates.
- 29 December 2023
- Published by Springer Nature in Research Square
Open AccessSpondias mombin flavonoids showed super-binder ability with Downstream Molecular Targets of Parkinson’s Disease: Folkloric-therapy assessment as a Scaffold for Structural Studies in Neurodegenerative disease
Spondias mombin (S. mombin), a prominent botanical resource, has garnered recognition within folkloric therapy. Parkinson's disease (PD), characterized by dopaminergic neuron attrition in the substantia nigra, manifests as motor anomalies like tremors, rigidity, and bradykinesia. This study capitalizes on S. mombin's reservoir of 100 characterized phytocompounds and employs computational methodologies to interrogate their potential 35 PD-associated target proteins. Employing a multifaceted approach, we engaged in molecular docking, ADMET predictions, Molecular Mechanics/Generalized Born Surface Area (MM/GBSA) evaluations, Density Functional Theory (DFT), and Molecular Dynamic Simulations (MDS). This comprehensive framework facilitated insightful structural assessments and predictive analyses. Impressively, flavonoids hailing from S. mombin, including quercetin, catechin, ellagic acid, and epicatechin, showcased optimal binding affinities for PD-relevant target proteins. Moreover, these identified ligands exhibited minimal signs of mutagenicity, tumorigenicity, or irritancy, except for quercetin, which displayed elevated tumorigenic potential. Notably, quercetin and dopamine exhibited varying band gap energies, with quercetin the lowest (3.63 eV) and dopamine the highest (5.76 eV) values. MDS result suggests a synergistic outcome based on the RMSD and RMSF graphs for quercetin highlighting it as the best of all including the co-ligand. In a collective sense, our findings present S. mombin as promising reservoirs of active pharmaceutical ingredients, warranting further exploration for novel PD therapeutic avenues. Consequently, this study underscores the enhanced efficacy of phyto-ligands sourced from S. mombin, advocating their optimization as potential drug candidates.
- 27 October 2022
- Published by Bioscientifica in Endocrine Abstracts
- Vol. 86
Vernonia amygdalina Alleviates Neurodegenerative Effects of High Fat Diet and Streptozotocin-Induced Type 2 Diabetes Mellitus in the Hippocampi of Adult Male Wistar Rats
Cognitive impairment and neurodegeneration are a few hallmarks of brain insulin resistance, a core feature of Type 2 diabetes mellitus (T2DM). Using a Wistar rat model of a high-fat diet and streptozotocin-induced T2DM, we aimed to determine the potential of Vernonia amygdalina (VA) as a possible treatment for the accompanied neurodegenerative effects of this condition on hippocampal structure and function. T2DM adult rats were prepared by a combination of a high-fat diet and intraperitoneal injection of 35 mg/kg streptozocin. The elevated plus and Barnes maze tests were used to evaluate anxiety, learning, and memory functions, followed by H&E and cresyl violet staining, immunohistochemical staining for hippocampal amyloid beta, synaptophysin, and glial fibrillary acid protein (GFAP), and RNA analysis of P53, P21, glutathione (GSH) and glutathione peroxidase (GPX-1) genes expression levels. T2DM model animals had significantly reduced open arm entries and duration and higher escape latencies, depicting increased anxiety and decreased spatial memory and learning abilities(P<0.05). Expression changes were evident for P53, GSH, P21, and GPX-1 genes, which included an increased expression of P53 and P21 in the hippocampus of T2DM model animals and a slight reduction of these genes in VA groups, and an increased expression of GSH in T2DM and VA groups. Also, photomicrographs revealed a fragmented pyramidal cell layer with visible pyknotic cells and a gross reduction in cytoplasmic Nissl proteins across the Cornus Ammonis and dentate gyrus regions of the hippocampi. Similarly, increased expression of amyloid-beta, synaptophysin, and GFAP was seen in these regions. However, V. amygdalina was able to enhance the learning and memory abilities of T2DM rats, replenish hippocampal pyramidal neurons, and help improve hippocampal synapses, while improving the brain’s antioxidant defense system. These findings may provide helpful insights into the treatment of T2DM-induced brain insulin resistance.
- 27 October 2022
- Published by Bioscientifica in Endocrine Abstracts
- Vol. 86
Vernonia amygdalina Alleviates Neurodegenerative Effects of High Fat Diet and Streptozotocin-Induced Type 2 Diabetes Mellitus in the Hippocampi of Adult Male Wistar Rats
Cognitive impairment and neurodegeneration are a few hallmarks of brain insulin resistance, a core feature of Type 2 diabetes mellitus (T2DM). Using a Wistar rat model of a high-fat diet and streptozotocin-induced T2DM, we aimed to determine the potential of Vernonia amygdalina (VA) as a possible treatment for the accompanied neurodegenerative effects of this condition on hippocampal structure and function. T2DM adult rats were prepared by a combination of a high-fat diet and intraperitoneal injection of 35 mg/kg streptozocin. The elevated plus and Barnes maze tests were used to evaluate anxiety, learning, and memory functions, followed by H&E and cresyl violet staining, immunohistochemical staining for hippocampal amyloid beta, synaptophysin, and glial fibrillary acid protein (GFAP), and RNA analysis of P53, P21, glutathione (GSH) and glutathione peroxidase (GPX-1) genes expression levels. T2DM model animals had significantly reduced open arm entries and duration and higher escape latencies, depicting increased anxiety and decreased spatial memory and learning abilities(P<0.05). Expression changes were evident for P53, GSH, P21, and GPX-1 genes, which included an increased expression of P53 and P21 in the hippocampus of T2DM model animals and a slight reduction of these genes in VA groups, and an increased expression of GSH in T2DM and VA groups. Also, photomicrographs revealed a fragmented pyramidal cell layer with visible pyknotic cells and a gross reduction in cytoplasmic Nissl proteins across the Cornus Ammonis and dentate gyrus regions of the hippocampi. Similarly, increased expression of amyloid-beta, synaptophysin, and GFAP was seen in these regions. However, V. amygdalina was able to enhance the learning and memory abilities of T2DM rats, replenish hippocampal pyramidal neurons, and help improve hippocampal synapses, while improving the brain’s antioxidant defense system. These findings may provide helpful insights into the treatment of T2DM-induced brain insulin resistance.
- Open Access
- 19 October 2022
- Published by SAGE Publications in Annals of Neurosciences
- Vol. 30 (2) , 84-95
Peroral Exposure to Cannabis Sativa Ethanol Extract Caused Neuronal Degeneration and Astrogliosis in Wistar Rats’ Prefrontal Cortex
Background: Despite widespread concerns about its possible side effects, notably on the prefrontal cortex (PFC), which mediates cognitive processes, the use of Cannabis sativa as a medicinal and recreational drug is expanding exponentially. This study evaluated possible behavioral alterations, neurotransmitter levels, histological, and immunohistochemical changes in the PFC of Wistar rats exposed to Cannabis sativa. Purpose: To evaluate the effect of graded doses of Cannabis sativa on the PFC using behavioural, histological, and immunohistochemical approaches. Methods: Twenty-eight juvenile male Wistar rats weighing between 70 g and 100 g were procured and assigned into groups A-D ( n = 7 each). Group A served as control which received distilled water only as a placebo; rats in groups B, C, and D which were the treatment groups were orally exposed to graded doses of Cannabis sativa (10 mg/kg, 50 mg/kg, and 100 mg/kg, respectively). Rats in all experimental groups were exposed to Cannabis sativa for 21 days, followed by behavioral tests using the open field test for locomotor, anxiety, and exploratory activities, while the Y-maze test was for spatial memory assessment. Rats for biochemical analysis were cervically dislocated and rats for tissue processing were intracardially perfused following neurobehavioral tests. Sequel to sacrifice, brain tissues were excised and prefrontal cortices were obtained for the neurotransmitter (glutamate, acetylcholine, and dopamine) and enzymatic assay (Cytochrome C oxidase (CcO) and Glucose 6- Phosphate Dehydrogenase-G-6-PDH). Brain tissues were fixed in 10% Neutral Buffered Formalin (NBF) for histological demonstration of the PFC cytoarchitecture using H&E and glial fibrillary acidic protein (GFAP) for astrocyte evaluation. Results: Glutamate and dopamine levels were significantly increased ( F = 24.44, P = .0132) in groups D, and B, C, and D, respectively, compared to control; likewise, the activities of CcO and G-6-PDH were also significantly elevated ( F = 96.28, P = .0001) ( F = 167.5, P = .0001) in groups C and D compared to the control. Cannabis sativa impaired locomotor activity and spatial memory in B and D and D, respectively. All Cannabis sativa exposed groups demonstrated evidence of neurodegeneration in the exposed groups; GFAP immunoexpression was evident in all groups with a marked increase in group D. Conclusion: Cannabis sativa altered neurotransmitter levels, energy metabolism, locomotor, and exploratory activity, and spatial working memory, with neuronal degeneration as well as reactive astrogliosis in the PFC.
- 19 October 2022
- Published by SAGE Publications in Annals of Neurosciences
- Vol. 30 (2) , 84-95
Open AccessPeroral Exposure to Cannabis Sativa Ethanol Extract Caused Neuronal Degeneration and Astrogliosis in Wistar Rats’ Prefrontal Cortex
Background: Despite widespread concerns about its possible side effects, notably on the prefrontal cortex (PFC), which mediates cognitive processes, the use of Cannabis sativa as a medicinal and recreational drug is expanding exponentially. This study evaluated possible behavioral alterations, neurotransmitter levels, histological, and immunohistochemical changes in the PFC of Wistar rats exposed to Cannabis sativa. Purpose: To evaluate the effect of graded doses of Cannabis sativa on the PFC using behavioural, histological, and immunohistochemical approaches. Methods: Twenty-eight juvenile male Wistar rats weighing between 70 g and 100 g were procured and assigned into groups A-D ( n = 7 each). Group A served as control which received distilled water only as a placebo; rats in groups B, C, and D which were the treatment groups were orally exposed to graded doses of Cannabis sativa (10 mg/kg, 50 mg/kg, and 100 mg/kg, respectively). Rats in all experimental groups were exposed to Cannabis sativa for 21 days, followed by behavioral tests using the open field test for locomotor, anxiety, and exploratory activities, while the Y-maze test was for spatial memory assessment. Rats for biochemical analysis were cervically dislocated and rats for tissue processing were intracardially perfused following neurobehavioral tests. Sequel to sacrifice, brain tissues were excised and prefrontal cortices were obtained for the neurotransmitter (glutamate, acetylcholine, and dopamine) and enzymatic assay (Cytochrome C oxidase (CcO) and Glucose 6- Phosphate Dehydrogenase-G-6-PDH). Brain tissues were fixed in 10% Neutral Buffered Formalin (NBF) for histological demonstration of the PFC cytoarchitecture using H&E and glial fibrillary acidic protein (GFAP) for astrocyte evaluation. Results: Glutamate and dopamine levels were significantly increased ( F = 24.44, P = .0132) in groups D, and B, C, and D, respectively, compared to control; likewise, the activities of CcO and G-6-PDH were also significantly elevated ( F = 96.28, P = .0001) ( F = 167.5, P = .0001) in groups C and D compared to the control. Cannabis sativa impaired locomotor activity and spatial memory in B and D and D, respectively. All Cannabis sativa exposed groups demonstrated evidence of neurodegeneration in the exposed groups; GFAP immunoexpression was evident in all groups with a marked increase in group D. Conclusion: Cannabis sativa altered neurotransmitter levels, energy metabolism, locomotor, and exploratory activity, and spatial working memory, with neuronal degeneration as well as reactive astrogliosis in the PFC.
- Open Access
- 1 November 2021
- Published by Elsevier in Phytomedicine Plus
- Vol. 1 (4) , 100104
Aluminium chloride-induced hippocampal damage: CA3 hippocampal subfield involvement and the neuroprotective role of Buchholzia coriacea ethanolic seed extract
- 1 November 2021
- Published by Elsevier in Phytomedicine Plus
- Vol. 1 (4) , 100104
Open AccessAluminium chloride-induced hippocampal damage: CA3 hippocampal subfield involvement and the neuroprotective role of Buchholzia coriacea ethanolic seed extract
- Open Access
- 1 April 2021
- Published by Medknow in Journal of Human Reproductive Sciences
- Vol. 14 (2) , 113-120
Observable Protective Activities of Quercetin on Aluminum Chloride-Induced Testicular Toxicity in Adult Male Wistar Rat
Background: Aluminum chloride (AlCl3) present in many manufactured consumable is considered as a toxic element. Aim: Our study evaluates the toxic effects induced by AlCl3 on the testes as well as the therapeutic tendency of Quercetin (QUE) agent as an antioxidant. Setting and Design: In the department of Anatomy of Medical School. Methods and Materials: Thirty-two male Wistar rats weighing approximately 170 ± 10 g were assigned into four groups with eight each, fed with rat chow and water ad-libitum. Group A served as control and was given distilled water throughout; Group B was given only QUE (200 mg/kg body weight) for 21 days; Group C was given only AlCl3 (300 mg/kg body weight) for 14 days; and Group D was given AlCl3 (300 mg/kg body weight) for 14 days followed with QUE (200 mg/kg body weight) for 21 days. Substance administrations were done orally. Statistical analysis: One-way analysis of variance was used to analyze the data, in GraphPad Prism 6.0 being the statistical software. Results: AlCl3 significantly reduced the relative organ (testes) weight, correlating the decrease in sperm count, sperm motility and sperm viability. Furthermore, there was a decrease in luteinizing hormone with an increase in follicle-stimulating hormone which accounted for a significant reduction in testosterone level that plays a great role in spermatogenesis, following AlCl3 treatment. The cytoarchitecture of the testes showed degenerative changes in the seminiferous tubules and leydin cells, nitric oxide synthases immunoreactivity was intense in the seminiferous epithelium of rat in Group C. Conclusion: These suggest that QUE antioxidant property could reverse the decrease in sperm status, hormonal effects, and functional deficit induced by aluminum chloride on the testes of Wistar rats.
- 1 April 2021
- Published by Medknow in Journal of Human Reproductive Sciences
- Vol. 14 (2) , 113-120
Open AccessObservable Protective Activities of Quercetin on Aluminum Chloride-Induced Testicular Toxicity in Adult Male Wistar Rat
Background: Aluminum chloride (AlCl3) present in many manufactured consumable is considered as a toxic element. Aim: Our study evaluates the toxic effects induced by AlCl3 on the testes as well as the therapeutic tendency of Quercetin (QUE) agent as an antioxidant. Setting and Design: In the department of Anatomy of Medical School. Methods and Materials: Thirty-two male Wistar rats weighing approximately 170 ± 10 g were assigned into four groups with eight each, fed with rat chow and water ad-libitum. Group A served as control and was given distilled water throughout; Group B was given only QUE (200 mg/kg body weight) for 21 days; Group C was given only AlCl3 (300 mg/kg body weight) for 14 days; and Group D was given AlCl3 (300 mg/kg body weight) for 14 days followed with QUE (200 mg/kg body weight) for 21 days. Substance administrations were done orally. Statistical analysis: One-way analysis of variance was used to analyze the data, in GraphPad Prism 6.0 being the statistical software. Results: AlCl3 significantly reduced the relative organ (testes) weight, correlating the decrease in sperm count, sperm motility and sperm viability. Furthermore, there was a decrease in luteinizing hormone with an increase in follicle-stimulating hormone which accounted for a significant reduction in testosterone level that plays a great role in spermatogenesis, following AlCl3 treatment. The cytoarchitecture of the testes showed degenerative changes in the seminiferous tubules and leydin cells, nitric oxide synthases immunoreactivity was intense in the seminiferous epithelium of rat in Group C. Conclusion: These suggest that QUE antioxidant property could reverse the decrease in sperm status, hormonal effects, and functional deficit induced by aluminum chloride on the testes of Wistar rats.
- Open Access
- 1 November 2020
- Published by Taylor & Francis in Journal of Experimental Pharmacology
- Vol. ume 12, 439-446
Zingiber officinale Ethanolic Extract Attenuated Reserpine-Induced Depression-Like Condition and Associated Hippocampal Aberrations in Experimental Wistar Rats
Background: Repeated and regimented treatment with reserpine causes depression-like condition characterized by persistent mood disorder, feelings of severe despondency and dejection, thus altering the hippocampal morphology. Our study compared a well-known antidepressant (fluoxetine), with the potential of Zingiber officinale to ameliorate reserpine-induced depression and the associated hippocampal cornu ammonis 1 (CA1) neuronal cell damage. Methods: Forty-eight male Wistar rats, weighing 130– 160 g, were randomly assigned to 6 groups (n=8), housed in plastic cages under natural light and dark cycles at room temperature with access to feed and water ad libitum. Group-A (control) received distilled water. Group-B and Group-C orally received 400 mg/kg of Zingiber officinale and 10 mg/kg of fluoxetine, respectively, for 7 days, while Group-D intraperitoneally received 0.2 mg/kg of reserpine for 14 days. Group-E and Group-F intraperitoneally received 0.2 mg/kg of reserpine for 14 days followed by 400 mg/kg of Zingiber officinale and 10 mg/kg of fluoxetine respectively for 7 days. All animals were sacrificed by cervical dislocation at the end of experiment, and the brains hippocampi were dissected, excised and processed for various analyses including histology [H&E], histochemistry of GFAP expression by astrocytes and specific gene expressions including p53 gene, glutathione reductase (GSR), glutathione peroxidase and catalase (CAT). Results: Reserpine significantly depleted the expression of P53 and glutathione reductase (GSR) genes while significantly increasing the expression of glutathione peroxidase 1 (GPx-1) gene (P≤ 0.05). Also, a marked increase in the expression of catalase (CAT) gene was observed. Furthermore, histoarchitecture (photomicrographs) of hippocampus CA1 region showed disruption in the arrangement of pyramidal neurons and alterations in their morphologies when animals were treated with reserpine (Group D). There was also accompanying increased astrocyte densities within the CA1 region following reserpine treatment. These features indicated deleterious effects of reserpine. Both Zingiber officinale and fluoxetine treatments ameliorated these effects. Conclusion: These findings showed structural and molecular alterations associated with reserpine-induced depression. Also, Zingiber officinale was effective to provide ameliorative and protective effects against the neurotoxic effects of reserpine in the hippocampus, making it a potential candidate for treating depression and its associated neurodegenerative diseases.
- 1 November 2020
- Published by Taylor & Francis in Journal of Experimental Pharmacology
- Vol. ume 12, 439-446
Open AccessZingiber officinale Ethanolic Extract Attenuated Reserpine-Induced Depression-Like Condition and Associated Hippocampal Aberrations in Experimental Wistar Rats
Background: Repeated and regimented treatment with reserpine causes depression-like condition characterized by persistent mood disorder, feelings of severe despondency and dejection, thus altering the hippocampal morphology. Our study compared a well-known antidepressant (fluoxetine), with the potential of Zingiber officinale to ameliorate reserpine-induced depression and the associated hippocampal cornu ammonis 1 (CA1) neuronal cell damage. Methods: Forty-eight male Wistar rats, weighing 130– 160 g, were randomly assigned to 6 groups (n=8), housed in plastic cages under natural light and dark cycles at room temperature with access to feed and water ad libitum. Group-A (control) received distilled water. Group-B and Group-C orally received 400 mg/kg of Zingiber officinale and 10 mg/kg of fluoxetine, respectively, for 7 days, while Group-D intraperitoneally received 0.2 mg/kg of reserpine for 14 days. Group-E and Group-F intraperitoneally received 0.2 mg/kg of reserpine for 14 days followed by 400 mg/kg of Zingiber officinale and 10 mg/kg of fluoxetine respectively for 7 days. All animals were sacrificed by cervical dislocation at the end of experiment, and the brains hippocampi were dissected, excised and processed for various analyses including histology [H&E], histochemistry of GFAP expression by astrocytes and specific gene expressions including p53 gene, glutathione reductase (GSR), glutathione peroxidase and catalase (CAT). Results: Reserpine significantly depleted the expression of P53 and glutathione reductase (GSR) genes while significantly increasing the expression of glutathione peroxidase 1 (GPx-1) gene (P≤ 0.05). Also, a marked increase in the expression of catalase (CAT) gene was observed. Furthermore, histoarchitecture (photomicrographs) of hippocampus CA1 region showed disruption in the arrangement of pyramidal neurons and alterations in their morphologies when animals were treated with reserpine (Group D). There was also accompanying increased astrocyte densities within the CA1 region following reserpine treatment. These features indicated deleterious effects of reserpine. Both Zingiber officinale and fluoxetine treatments ameliorated these effects. Conclusion: These findings showed structural and molecular alterations associated with reserpine-induced depression. Also, Zingiber officinale was effective to provide ameliorative and protective effects against the neurotoxic effects of reserpine in the hippocampus, making it a potential candidate for treating depression and its associated neurodegenerative diseases.